(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

The recent correction in the Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) has many passive income investors wondering if ...

Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...

The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...

An experimental muscle-preserving drug called bimagrumab helped people taking semaglutide (Ozempic/Wegovy) keep their muscle ...

Novo Nordisk has launched Wegovy, a once-weekly weight-loss injection, in India. The drug aims to manage obesity and reduce ...

Danish pharma giant Novo Nordisk on Tuesday launched its blockbuster weight loss drug Wegovy as a once-a-week injection in ...

A Chinese-developed GLP-1 drug is as effective as Ozempic or Zepbound, clinical trial says ...

Hims & Hers delivered record Q1 results and expanded into Europe with the Zava acquisition. Click here to see why HIMS stock is a Hold.

Dear Dr. Roach: What is the recommended daily protein allowance for older adults? I am in my 70s. — P.R.

It’s a shot at better health that comes with a promise to help shed the pounds. Demand for drugs like Ozempic, Wegovy, Mounjaro and Zepbound continues to grow. FILE – Donna ...

Too often, organizations see research as something that must deliver immediate commercial value. They ask, “What’s the business case?” but overlook how true innovation happens. It begins with ...